EVR Research’s Enovis ENOV Stock Holding History

EVR Research’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-225,000	Closed	-$5.12M	–	32
2026 Q1	$5.12M	Buy	+225,000	New	+$5.32M	2.05%	14
2024 Q4	–	Sell	-85,000	Closed	-$794K	–	41
2024 Q3	$794K	Buy	+85,000	New	+$3.79M	0.2%	34

Other funds holding ENOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EVR Research's ENOV Position: Q2 2026 in Review

EVR Research sold out of Enovis (ENOV) in Q2 2026, closing a stake of 225,000 shares — an estimated $5.12M sold.

EVR Research first reported a position in ENOV in Q3 2024 and held it in 2 quarters. The position peaked at $5.12M in Q1 2026. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

EVR Research reported no remaining Enovis position as of Q2 2026 after selling out during the quarter.
EVR Research sold 225,000 Enovis shares in Q2 2026, an estimated $5.12M.
EVR Research first reported a position in Enovis in Q3 2024 and held it in 2 quarters.
EVR Research's Enovis position peaked at $5.12M in Q1 2026.
251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on EVR Research's 13F filing for Q2 2026, filed 13 Aug 2026.